Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population

This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were rec...

Full description

Saved in:
Bibliographic Details
Published inHuman vaccines & immunotherapeutics Vol. 17; no. 10; pp. 3365 - 3370
Main Authors Chaudhary, Farooq Ahmad, Ahmad, Basaruddin, Khalid, Muhammad Danial, Fazal, Ayesha, Javaid, Muhammad Mohsin, Butt, Danial Qasim
Format Journal Article
LanguageEnglish
Published Taylor & Francis 03.10.2021
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group (p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease.
AbstractList This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group (p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease.This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group (p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease.
This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group (p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease.
This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group ( p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease.
Author Chaudhary, Farooq Ahmad
Ahmad, Basaruddin
Butt, Danial Qasim
Khalid, Muhammad Danial
Javaid, Muhammad Mohsin
Fazal, Ayesha
Author_xml – sequence: 1
  givenname: Farooq Ahmad
  orcidid: 0000-0002-1748-0413
  surname: Chaudhary
  fullname: Chaudhary, Farooq Ahmad
  email: chaudhary4@hotmail.com
  organization: Shaheed Zulfiqar Ali Bhutto Medical University
– sequence: 2
  givenname: Basaruddin
  orcidid: 0000-0003-3088-0558
  surname: Ahmad
  fullname: Ahmad, Basaruddin
  organization: Universiti Sains Malaysia
– sequence: 3
  givenname: Muhammad Danial
  orcidid: 0000-0001-9788-644X
  surname: Khalid
  fullname: Khalid, Muhammad Danial
  organization: HITEC Institute of Medical Sciences
– sequence: 4
  givenname: Ayesha
  surname: Fazal
  fullname: Fazal, Ayesha
  organization: Shaheed Zulfiqar Ali Bhutto Medical University
– sequence: 5
  givenname: Muhammad Mohsin
  surname: Javaid
  fullname: Javaid, Muhammad Mohsin
  organization: Shaheed Zulfiqar Ali Bhutto Medical University
– sequence: 6
  givenname: Danial Qasim
  surname: Butt
  fullname: Butt, Danial Qasim
  organization: HITEC Institute of Medical Sciences
BookMark eNqFkV9vFCEUxYmpse3aj2Ayj77MCgx_ZmJiNKvVTZrUBzU-mBB25rJLZWAKMzX77cu4W5P6oLwAB86Pyz3n6MQHDwi9IHhJcI1fUSIY54QvKaZkSRrGJKueoLNZLzln30_-rAk_RRcp3eA8JKZMiGfotGK0Eg2nZ-jHpW7HEFNhvXET-Nb6bbG6_rZ-X5KmuNNtFqDYQbKj9u2-0L4rsgjDvIVC9yHfH3dQfNY_bcqiLYYwTE6PNvjn6KnRLsHFcV6gr5cfvqw-lVfXH9erd1dlywkZyypX3FEpm0YYXVFJBOEAVWMYFVKLGjORv2k6STDwhtamqomG7MCN0B1j1QKtD9wu6Bs1RNvruFdBW_VbCHGrdBxt60BxArlnfNPUlLKNhNp0mZyRmGMwncisNwfWMG166FrwY9TuEfTxibc7tQ13qmaVnGNYoJdHQAy3E6RR9Ta14Jz2EKakKOeYCkrk_Nbrw9U2hpQiGNXmNs-dy2TrFMFqjls9xK3muNUx7uzmf7kfivyf7-3BlyMPsde_QnSdGvXehWhijtUmVf0bcQ8GyMCS
CitedBy_id crossref_primary_10_3390_vaccines11061052
crossref_primary_10_1108_IJHG_05_2024_0049
crossref_primary_10_1371_journal_pgph_0003564
crossref_primary_10_2147_PPA_S376103
crossref_primary_10_1155_2022_2313367
crossref_primary_10_1080_13549839_2022_2155937
crossref_primary_10_1111_ijn_13144
crossref_primary_10_1016_j_soh_2023_100048
crossref_primary_10_1108_JPMH_02_2023_0016
crossref_primary_10_1177_20552076231211670
crossref_primary_10_1089_hs_2024_0049
crossref_primary_10_1080_21645515_2021_2013080
crossref_primary_10_1080_21645515_2023_2180969
crossref_primary_10_4103_jfmpc_jfmpc_1255_21
crossref_primary_10_2139_ssrn_4139623
crossref_primary_10_1080_21645515_2024_2369358
crossref_primary_10_7717_peerj_cs_1111
crossref_primary_10_3389_fpubh_2022_1033473
crossref_primary_10_1155_2021_8963168
crossref_primary_10_3390_vaccines10071095
crossref_primary_10_1371_journal_pone_0286794
crossref_primary_10_1016_j_vaccine_2024_126168
crossref_primary_10_1136_bmjopen_2022_064096
crossref_primary_10_3390_vaccines10111777
crossref_primary_10_55908_sdgs_v11i10_788
crossref_primary_10_1007_s40609_023_00268_9
crossref_primary_10_1080_21645515_2023_2228164
crossref_primary_10_1002_iid3_70076
crossref_primary_10_1080_21645515_2022_2068930
crossref_primary_10_2147_RMHP_S370125
crossref_primary_10_7759_cureus_19106
crossref_primary_10_1080_21645515_2021_1968215
crossref_primary_10_34172_hpp_2023_03
crossref_primary_10_7759_cureus_49576
crossref_primary_10_3390_ijerph191811531
crossref_primary_10_1080_21645515_2022_2054261
crossref_primary_10_3389_fpubh_2024_1382849
crossref_primary_10_3390_vaccines10101736
crossref_primary_10_1186_s12877_023_04518_5
crossref_primary_10_1371_journal_pgph_0002652
crossref_primary_10_1080_21645515_2021_2010426
crossref_primary_10_1186_s12982_024_00236_4
crossref_primary_10_1016_j_pedn_2022_01_015
crossref_primary_10_1080_13648470_2024_2386887
crossref_primary_10_3390_vaccines10010110
crossref_primary_10_3346_jkms_2023_38_e326
crossref_primary_10_1038_s41562_022_01431_6
crossref_primary_10_3389_fmed_2021_783982
crossref_primary_10_3389_fpubh_2022_841842
crossref_primary_10_1186_s13690_022_00904_4
crossref_primary_10_1080_01436597_2021_1995713
crossref_primary_10_3390_ijerph19031305
crossref_primary_10_1007_s44196_022_00069_6
crossref_primary_10_1007_s10389_022_01728_w
crossref_primary_10_1136_bmjopen_2023_075297
crossref_primary_10_26900_hsq_2113
crossref_primary_10_3390_ijerph191912892
crossref_primary_10_1007_s12144_022_03622_w
crossref_primary_10_3389_fpubh_2022_1100130
crossref_primary_10_1371_journal_pone_0290412
crossref_primary_10_1371_journal_pone_0270023
crossref_primary_10_3389_fendo_2023_1172089
crossref_primary_10_3390_vaccines10071076
crossref_primary_10_36740_WLek202209114
crossref_primary_10_37762_jgmds_10_3_460
crossref_primary_10_1016_j_puhe_2023_01_014
crossref_primary_10_3390_vaccines9121384
crossref_primary_10_3390_ijerph20237093
crossref_primary_10_1080_21645515_2022_2050121
crossref_primary_10_1186_s41182_022_00453_0
Cites_doi 10.1038/s41591-020-1124-9
10.1377/hlthaff.24.3.611
10.3390/ijerph17217818
10.1016/j.vaccine.2015.04.036
10.3390/vaccines8010002
10.4161/hv.24657
10.1016/S0140-6736(21)00085-4
10.1016/j.ijid.2020.03.017
10.1016/j.ijsu.2020.04.018
10.1016/j.ijid.2020.12.029
10.1093/tbm/ibaa090
10.1007/s10654-021-00728-6
10.3389/fpubh.2020.00381
10.3390/vaccines9010042
10.1186/1471-2458-13-511
10.1371/journal.pone.0248892
10.1186/s12992-016-0195-3
10.1038/s41467-020-20226-9
10.3389/fpsyg.2020.577684
10.4269/ajtmh.20-0654
10.1186/s41256-021-00188-1
10.1016/j.vaccine.2015.04.035
10.3390/vaccines8030482
10.1038/s41418-020-00720-9
10.22541/au.161519250.03425961/v1
10.1002/1348-9585.12168
10.1007/s10198-020-01208-6
10.3390/vaccines8040582
ContentType Journal Article
Copyright 2021 Taylor & Francis Group, LLC 2021
2021 Taylor & Francis Group, LLC 2021 Taylor & Francis
Copyright_xml – notice: 2021 Taylor & Francis Group, LLC 2021
– notice: 2021 Taylor & Francis Group, LLC 2021 Taylor & Francis
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1080/21645515.2021.1944743
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate F. A. CHAUDHARY ET AL
EISSN 2164-554X
EndPage 3370
ExternalDocumentID oai_doaj_org_article_51e2025b98224b7e8fd1fd8f3050efd6
PMC8437474
10_1080_21645515_2021_1944743
1944743
Genre Research Article
GrantInformation_xml – fundername: did not receive
GroupedDBID ---
00X
0YH
30N
4.4
53G
AALUX
ABEIZ
ABUPF
ACENM
ACGFS
ADBBV
ADCVX
AECIN
AENEX
AEXWM
AGYJP
AIJEM
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AOIJS
ARJSQ
BABNJ
BAWUL
BLEHA
BOHLJ
CCCUG
DGEBU
DIK
EBS
H13
HYE
IPNFZ
KYCEM
LJTGL
M4Z
O9-
RIG
RPM
TDBHL
TFL
TFW
TTHFI
AAYXX
CITATION
7X8
5PM
GROUPED_DOAJ
ID FETCH-LOGICAL-c511t-3554d277996fa3271615ee39f4267a68046021fd710e5928f381aed27096ad443
IEDL.DBID DOA
ISSN 2164-5515
2164-554X
IngestDate Wed Aug 27 01:30:15 EDT 2025
Thu Aug 21 14:09:06 EDT 2025
Fri Jul 11 00:48:14 EDT 2025
Tue Jul 01 02:46:14 EDT 2025
Thu Apr 24 22:55:09 EDT 2025
Wed Dec 25 09:06:36 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c511t-3554d277996fa3271615ee39f4267a68046021fd710e5928f381aed27096ad443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1748-0413
0000-0001-9788-644X
0000-0003-3088-0558
OpenAccessLink https://doaj.org/article/51e2025b98224b7e8fd1fd8f3050efd6
PMID 34236952
PQID 2550262176
PQPubID 23479
PageCount 6
ParticipantIDs informaworld_taylorfrancis_310_1080_21645515_2021_1944743
doaj_primary_oai_doaj_org_article_51e2025b98224b7e8fd1fd8f3050efd6
crossref_citationtrail_10_1080_21645515_2021_1944743
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8437474
crossref_primary_10_1080_21645515_2021_1944743
proquest_miscellaneous_2550262176
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-10-03
PublicationDateYYYYMMDD 2021-10-03
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-03
  day: 03
PublicationDecade 2020
PublicationTitle Human vaccines & immunotherapeutics
PublicationYear 2021
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References e_1_3_2_27_1
e_1_3_2_28_1
e_1_3_2_29_1
e_1_3_2_20_1
e_1_3_2_22_1
e_1_3_2_23_1
e_1_3_2_24_1
e_1_3_2_25_1
e_1_3_2_26_1
Funk C (e_1_3_2_15_1) 2020
Volkman JE (e_1_3_2_21_1) 2020
e_1_3_2_16_1
e_1_3_2_9_1
e_1_3_2_17_1
e_1_3_2_18_1
e_1_3_2_7_1
Felter C (e_1_3_2_8_1) 2021
e_1_3_2_19_1
e_1_3_2_2_1
e_1_3_2_31_1
e_1_3_2_30_1
e_1_3_2_10_1
e_1_3_2_33_1
e_1_3_2_11_1
e_1_3_2_32_1
e_1_3_2_6_1
e_1_3_2_12_1
e_1_3_2_5_1
e_1_3_2_13_1
e_1_3_2_34_1
e_1_3_2_4_1
e_1_3_2_14_1
e_1_3_2_3_1
References_xml – ident: e_1_3_2_24_1
  doi: 10.1038/s41591-020-1124-9
– ident: e_1_3_2_32_1
  doi: 10.1377/hlthaff.24.3.611
– ident: e_1_3_2_9_1
  doi: 10.3390/ijerph17217818
– ident: e_1_3_2_11_1
  doi: 10.1016/j.vaccine.2015.04.036
– ident: e_1_3_2_16_1
  doi: 10.3390/vaccines8010002
– ident: e_1_3_2_13_1
  doi: 10.4161/hv.24657
– ident: e_1_3_2_7_1
  doi: 10.1016/S0140-6736(21)00085-4
– volume-title: Intent to get a COVID-19 vaccine rises to 60% as confidence in research and development process increases
  year: 2020
  ident: e_1_3_2_15_1
– ident: e_1_3_2_31_1
  doi: 10.1016/j.ijid.2020.03.017
– ident: e_1_3_2_5_1
  doi: 10.1016/j.ijsu.2020.04.018
– ident: e_1_3_2_29_1
  doi: 10.1016/j.ijid.2020.12.029
– ident: e_1_3_2_34_1
  doi: 10.1093/tbm/ibaa090
– ident: e_1_3_2_12_1
  doi: 10.1007/s10654-021-00728-6
– ident: e_1_3_2_25_1
  doi: 10.3389/fpubh.2020.00381
– ident: e_1_3_2_2_1
– ident: e_1_3_2_28_1
  doi: 10.3390/vaccines9010042
– ident: e_1_3_2_33_1
  doi: 10.1186/1471-2458-13-511
– ident: e_1_3_2_18_1
– ident: e_1_3_2_30_1
  doi: 10.1371/journal.pone.0248892
– ident: e_1_3_2_17_1
  doi: 10.1186/s12992-016-0195-3
– ident: e_1_3_2_20_1
  doi: 10.1038/s41467-020-20226-9
– ident: e_1_3_2_3_1
  doi: 10.3389/fpsyg.2020.577684
– ident: e_1_3_2_10_1
  doi: 10.4269/ajtmh.20-0654
– ident: e_1_3_2_22_1
  doi: 10.1186/s41256-021-00188-1
– start-page: 1
  year: 2020
  ident: e_1_3_2_21_1
  article-title: Information source’s influence on vaccine perceptions: an exploration into perceptions of knowledge, risk and safety
  publication-title: J Commun Healthc
– ident: e_1_3_2_14_1
  doi: 10.1016/j.vaccine.2015.04.035
– ident: e_1_3_2_26_1
  doi: 10.3390/vaccines8030482
– ident: e_1_3_2_6_1
  doi: 10.1038/s41418-020-00720-9
– ident: e_1_3_2_19_1
  doi: 10.22541/au.161519250.03425961/v1
– ident: e_1_3_2_4_1
  doi: 10.1002/1348-9585.12168
– ident: e_1_3_2_27_1
  doi: 10.1007/s10198-020-01208-6
– year: 2021
  ident: e_1_3_2_8_1
  article-title: What to know about the global COVID-19 vaccine rollout so far
  publication-title: Council Foreign Relat
– ident: e_1_3_2_23_1
  doi: 10.3390/vaccines8040582
SSID ssj0000702466
Score 2.5186522
Snippet This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing...
SourceID doaj
pubmedcentral
proquest
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 3365
SubjectTerms COVID-19 vaccine
Research Paper
vaccination misinformation
vaccine acceptance
vaccine hesitancy
Title Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population
URI https://www.tandfonline.com/doi/abs/10.1080/21645515.2021.1944743
https://www.proquest.com/docview/2550262176
https://pubmed.ncbi.nlm.nih.gov/PMC8437474
https://doaj.org/article/51e2025b98224b7e8fd1fd8f3050efd6
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PT9swFLYG0iQuCDYQHQN50q6miX_E7pHBKjZp7AKoByTLqV9EJZRWLCDx3_Oek1YNl152a9y4cvxe8r6vdr6Pse-mygMyCRCAH4QGUwgXXSbK6KwtwlSVht53_nNdXN3q3xMzWbP6oj1hrTxwO3FDkwPyc1OSzpwuLbgq5lV0FeZpBlVMYttY89bIVHoGW6w9aaFSIh8QCAvM8vUdlw2pjZqQHsr8DGm8tlr1ClPS73-nXtrDoP0dlGslabzHdjssyc_ba9hnH6D-xD627pKvn9n9uPXS4bPOiASrFL_4e_frUuQj_hKmtKbOH8gYgB6xPNSRYyMs6BB4siHiiA95hzLrGV-s7L4O2O34583FlejMFMQUMVUjCFdEaS3ymyooaQnpAahRhSXahsLRAqnEmUXEAWYkcYJdHgB7IMcJUWt1yLbreQ1HjOcRO0mjTBakDlksscSboACCKqKLcsD0cib9tFMaJ8OLR593gqTLAHgKgO8CMGBnq26LVmpjU4cfFKbVyaSUnRowf3yXP35T_gzYaD3Ivkl_lFStq4lXGwbwbZkRHu9KWmoJNcyf_3kkakhuke7h79teqvRG2_-mnj0kfW-nFZI8_eV_XN4x26ERp-2H6ivbbp6e4QRhVFOesi2VXZ-m--YN1ugT2w
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgEYILb0R5GomrS-JHnBxhoerCbrnsoj0gWU48ZitQWi0pEvx6ZvKompXQHvaWRyey3bH9ffb4G8bemJh6ZBIgAC-EBpOJPOSJKENubeYrVRo673y0yOYn-tOpOd05C0NhlcShYycU0Y7V1LlpMXoIiXsrEePjTG-Q3sl0ijRc4zx4nd0wRWbJ11Wy2K6zoEvLbsuSrASZDQd5_vel0RTVKvlf0DEdodFxLOXO5DS7y6qhWl1Myo_ppimn1d8Lio9Xq_c9dqfHrvxd52z32TWoH7CbXTbLPw_Zt1mXu4cv-8QnOCvy_S9fDz6ItOC_fUV7-PyMEhHQkM6xHBwfwppugbdpjzjiUd6j2nrJ19v0Yo_Yyezj8f5c9MkbRIUYrhGEY4K0FvlU9EpaQpYAqogICazPctqQlWkMiHDAFDKPCB08oAVyKh-0Vo_ZXr2q4QnjaUAjaZRJvNQ-CSVCCuMVgFdZyIOcMD38X67qlc0pwcZPl_YCqEPDOWo41zfchE23ZutO2uMyg_fkDNsfkzJ3-2B1_t31Hd2ZFNDGlKSLqEsLeQxYS6xeYhKIIZuwYteVXNMuzMQui4pTlxTg9eB3DkcB2trxNaw2vxwSQyTTSC_x-3bkkKPSjt_Uy7NWTzzXCkmlfnqFkr1it-bHR4fu8GDx-Rm7Ta_aiEf1nO015xt4gcitKV-2XfMfha4zNA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagFagXKI-qS3kYiauXxI8ke-yDVctj4UARByTLicd0Bcqu2ixS-fXMJM6qqYR66G032Yls79jzffH4G8bemJA6ZBIgAD8IDSYThS8SUfoizzNXqdLQeedPs-z4VL__bvpswouYVkkcOnRCEe1aTZN76UOfEfdWIsTHQG-Q3cl0jCxcYxi8yzYzOmhJpziS2fo1C3q07HYsyUqQWX-O539PGkSoVsj_mozpAIwOUymvxKbpQ1b2vepSUn6NV005rv5eE3y8Vbe32YOIXPl-52qP2B2oH7N7XS3Lyyfsx7Sr3MPnsewJxkR--PnbyZFIJ_yPq2gHn59RGQJa0Dk2g-NFWNJX4G3RI45olEdMW8_5cl1c7Ck7nb77engsYukGUSGCawShGC_zHNlUcErmhCsB1CQgIMhdVtB2rEyDR3wDZiKLgMDBAVogo3Jea7XDNupFDbuMpx6NpFEmcVK7xJcIKIxTAE5lvvByxHT_d9kq6ppTeY3fNo3yp_3AWRo4GwduxMZrs2Un7HGTwQH5wvrHpMvdXlic_7RxmluTAtqYklQRdZlDETz2EruXmASCz0ZsctWTbNO-lgldDRWrbmjA697tLK4BtLHjalisLizSQqTSSC7x-fnAHwetHd6p52etmnihFVJK_ewWLXvF7n85mtqPJ7MPe2yL7rTpjuo522jOV_ACYVtTvmwn5j-HkTHY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+influencing+COVID-19+vaccine+hesitancy+and+acceptance+among+the+Pakistani+population&rft.jtitle=Human+vaccines+%26+immunotherapeutics&rft.au=Farooq+Ahmad+Chaudhary&rft.au=Basaruddin+Ahmad&rft.au=Muhammad+Danial+Khalid&rft.au=Ayesha+Fazal&rft.date=2021-10-03&rft.pub=Taylor+%26+Francis+Group&rft.issn=2164-5515&rft.eissn=2164-554X&rft.volume=17&rft.issue=10&rft.spage=3365&rft.epage=3370&rft_id=info:doi/10.1080%2F21645515.2021.1944743&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_51e2025b98224b7e8fd1fd8f3050efd6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2164-5515&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2164-5515&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2164-5515&client=summon